Navigation Links
Array BioPharma Announces Proposed Public Offering Of Common Stock
Date:11/8/2012

feries.com; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by calling (866) 803-9204.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. 

Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements concerning the completion, timing and size of the proposed offering and other statements that are other than statements of historical facts. These statements involve significant risks and uncertainties. Because these statements reflect our current expectations concerning future events, our actual events could differ materially from those anticipated in these forward-looking statements as a result of many factors. These factors include, but are not limited to: the risk that the financing may be delayed or may not occur due to market or other conditions and the satisfaction of customary closing conditions related to the proposed public offering. Additional information concerning these and other factors that may cause actual events to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of Array's most recent Annual Report on Form 10-K, in our other periodic reports and filings with the Securities and Exchange Commission an
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
6. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
7. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
8. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
9. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
10. S1 Biopharma Expands Focus to Include Male Sexual Health
11. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Californie, 28 août 2014 ... le début des inclusions des patients ... des dispositifs expérimentaux (ou étude « IDE » ... l,innocuité et l,efficacité du système WEB™ ... Adam Arthur , professeur agrégé, ...
(Date:8/28/2014)... Calif. , Aug. 28, 2014  Sequent ... patient enrollment in an Investigational Device Exemption ("IDE") ... of the WEB™ Aneurysm Embolization System ("WEB"). ... Tennessee Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator ... in the study, treating them with the WEB ...
(Date:8/28/2014)... LAWRENCEVILLE, N.J. , Aug. 28, 2014  Celsion ... drug development company, today announced that Michael H. ... be presenting at the Rodman & Renshaw 16th Annual ... at 10:50 a.m. Eastern Time. The conference is being ... York City.  A copy of the presentation will be ...
Breaking Medicine Technology:Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference 2
... Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 ... enrollment in its randomized, double-blind Phase 2 clinical trial ... as TR-701) in patients with complicated skin and skin ... in 12 clinical sites in the United States, examined ...
... linked to psoriasis ANN ARBOR, Mich., Jan. 25 Scientists ... Dermatology , the U-M School of Public Health ... how genetic differences among individuals result in psoriasis, an autoimmune ... the findings could lead to new drug targets and tailored ...
Cached Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2Scientists Unmask Genetic Markers Associated With Psoriasis 2Scientists Unmask Genetic Markers Associated With Psoriasis 3Scientists Unmask Genetic Markers Associated With Psoriasis 4
(Date:8/28/2014)... 28, 2014 veEDIS Clinical Systems, ... Information System (EDIS), in Lawrence Medical Center, located ... physicians to document patient care, veEDIS is a ... as well as the authorized, confidential exchange of ... the veEDIS technology, designed in accordance with clinical ...
(Date:8/28/2014)... August 28, 2014 Vitals, a recognized and ... Sabrina Fabi of Cosmetic Laser Dermatology one of their ... thousands of patients to share their doctor experiences and rate ... face time, and follow-ups. The Vitals Top 10 Doctor recognition ... Fabi was ranked one of the highest by patients. , ...
(Date:8/28/2014)... Women must play a greater role in ... on the subject of women and water. Water researcher and ... for Water Partnership and United Nations-Water agree that when water ... Kelly was interviewed by Kleyne on the Sharon Kleyne Hour ... , Kathy Kelly became involved with global water issues as ...
(Date:8/28/2014)... It is not uncommon for people to sink ... Many face ridicule and judgment and find it easier to ... wondering why they keep gaining weight and just cannot seem ... foods, eating more and gaining more, leaving them feeling distain ... has helped thousands safely, successfully and rapidly improve their ...
(Date:8/28/2014)... The Baltimore Business Journal released rankings ... and awarded The Canton Group with the ... design, The Canton Group is the largest firm in ... Fortune 1000, higher education, health care, nonprofits, associations, and ... in web design and web development projects that a ...
Breaking Medicine News(10 mins):Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 3Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 2Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 3Health News:The Canton Group is Recognized by the Baltimore Business Journal as the Largest Web Design Firm in Baltimore 2
... giving and sharing, St.,David,s Community Health Foundation is delighted ... to area nonprofit organizations that provide,access to health care ... "Especially this year, we are mindful of the ... said Earl Maxwell, CEO of St. David,s,Community Health Foundation. ...
... Abt Associates announced that,Scott W. Royal, Ph.D., M.P.H., ... research programs, has been promoted to Division,Vice President and ... will,oversee the company,s Behavioral Health, Health Policy, and Public ... "We are very pleased that Scott has agreed ...
... one of the nation,s largest and most experienced Medicare contractors, ... joined the company,s board of directors. , ... 30 years of service with the federal agency that manages ... support plan for active-duty service members and retirees, and their ...
... College of Nursing faculty member, Rachel Jones, has been ... of Nursing Research at National Institutes of Health (NIH) to ... designed to reduce HIV sexual risk behavior in young women ... video-capable cell phones. , Jones, assistant professor at the College ...
... Mo. Pregnant women who experience intimate partner ... suffer adverse health effects, including depression, post traumatic ... University of Missouri researchers have found that women ... to seek health care for their infants than ...
... Milk campaign -- famous for,putting white ,staches on some of ... winning and multi-platinum selling artist, Usher, to,turn the creative dreams ... noise? music video program. , ... the chance to flex their,creative muscle by directing and producing ...
Cached Medicine News:Health News:$5.15 Million Provided to Support Local Health Care Needs 2Health News:$5.15 Million Provided to Support Local Health Care Needs 3Health News:$5.15 Million Provided to Support Local Health Care Needs 4Health News:Abt Associates Names Dr. Scott W. Royal to Lead Domestic Health Division 2Health News:Brian Rubin Joins TrailBlazer Health Enterprises' Board of Directors 2Health News:Rutgers College of Nursing faculty member tests cell phone videos to reduce HIV risk 2Health News:Abused women seek more infant health care, MU study finds 2Health News:Usher Teams With Body By Milk to Give Teens Once-in-a-Lifetime Opportunity 2Health News:Usher Teams With Body By Milk to Give Teens Once-in-a-Lifetime Opportunity 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: